On Wednesday, RBC Capital Markets adjusted its outlook on Sarepta Therapeutics (NASDAQ: SRPT) shares, reducing the price target from $87.00 to $58.00 while maintaining a Sector Perform rating.The ...

RBC Capital Markets maintained its Outperform rating on Target Corporation (NYSE:TGT) but lowered its price target from $112 ...

Analysts say Walmart's thinner margins and price-sensitive shoppers may have influenced the company's decision to speak out.

[Operator Instructions] I would now like to turn the conference over to Brian Ector, Senior Vice President, Capital Markets and Investor ... 152,000 BOE per day. In light of the current commodity ...

As an asset-light business, TSS is advantaged with ... from current uncertain macroeconomic conditions and volatile capital markets, against the landscape of strategic priorities under Pathway ...

Royal Bank of Canada's capital markets wing has established a new artificial intelligence and digital innovation team as it ...

Royal Bank of Canada's capital markets wing has established a new artificial intelligence and digital innovation team as it ...

As part of the expanded agreement, RBC Capital Markets’ Wealth Marketing Division will have an enterprise license for usage of OpenReel, Banzai’s leading digital video creation platform.

On Monday, RBC Capital Markets began coverage on Brunello Cucinelli SpA (BIT:BCU), an Italian luxury fashion brand, assigning a "Sector Perform" rating and setting a price target of €105.00.

BeiGene, which will change its name to BeOne Medicines, is a global oncology company that is discovering and developing innovative treatments that are more accessible and affordable to cancer ...

Banzai International, Inc. has announced an expanded agreement with RBC Capital Markets, which will allow RBC's Wealth Marketing Division to utilize Banzai's OpenReel digital video creation ...

Royal Bank of Canada missed analysts' quarterly profit estimates on Thursday as it set aside larger than expected sums of ...